Company: XOMAP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-109782
Chunk: 5

Company: XOMA Royalty Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1C
Chunk 5
---
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

XOMA ROYALTY CORPORATION 

CONDENSED CONSOLIDATED BALANCE SHEETS 

(unaudited)

(in thousands, except share and per share amounts)

​​​​​​​​​September 30, ​December 31, ​​2025​2024ASSETS​​​​​​Current assets:​​​​​​Cash and cash equivalents​$ 45,189​$ 101,654Short-term restricted cash​​ 45,288​​ 1,330Investment in equity securities​​ 1,521​​ 3,529Trade and other receivables, net​  3,573​  1,839Short-term royalty and commercial payment receivables under the EIR method​​ 13,269​​ 14,763Short-term royalty and commercial payment receivables under the cost recovery method​​ 900​​ 413Prepaid expenses and other current assets​  967​  2,076Total current assets​  110,707​  125,604​​​​​​​Long-term restricted cash​​ 40,076​  3,432Property and equipment, net​  24​  32Operating lease right-of-use assets​​ 272​​ 319Long-term royalty and commercial payment receivables under the EIR method​  4,678​  4,970Long-term royalty and commercial payment receivables under the cost recovery method​​ 57,864​​ 55,936Exarafenib milestone asset (Note 6)​  3,500​  3,214Investment in warrants​​ 595​​ —Intangible assets, net​​ 44,556​​ 25,909Other assets - long term​  879​  1,861Total assets​$ 263,151​$ 221,277​​​​​​​LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY​​​​​​Current liabilities:​​​​​​Accounts payable​$ 2,654​$ 1,053Accrued and other liabilities ​  4,134​  5,752Contingent consideration under RPAs, AAAs, and CPPAs​​ —​​ 3,000Operating lease liabilities​​ 2,508​​ 446Unearned revenue recognized under units-of-revenue method​  1,320​  1,361